Ignite Creation Date:
2024-05-05 @ 10:32 PM
Last Modification Date:
2024-10-26 @ 10:19 AM
Study NCT ID:
NCT01121588
Status:
TERMINATED
Last Update Posted:
2023-11-09
First Post:
2010-05-10
Brief Title:
An Investigational Drug Crizotinib PF-02341066 Is Being Studied In Tumors Except Non-Small Cell Lung Cancer That Are Positive For Anaplastic Lymphoma Kinase ALK
Sponsor:
Pfizer
Organization:
Pfizer
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-03-22
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-07
Completion Date Type:
ACTUAL
First Submit Date:
2010-05-10
First Submit QC Date:
May 10 2010
Study First Post Date:
2010-05-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-07
Last Update Post Date:
2023-11-09
Last Update Post Date Type:
ACTUAL